{"name":"CHU de Quebec-Universite Laval","slug":"chu-de-quebec-universite-laval","ticker":"","exchange":"","domain":"","description":"CHU de Quebec-Universite Laval is a leading academic health center in Quebec, Canada, dedicated to advancing medical research and patient care. The institution has a strong focus on clinical trials and innovative treatments, with a portfolio of 38 drugs in various stages of development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":9,"colorKey":"oncology","drugs":[{"name":"4CMenb","genericName":"4CMenb","slug":"4cmenb","indication":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B","status":"marketed"},{"name":"SASS","genericName":"SASS","slug":"sass","indication":"Other","status":"marketed"},{"name":"Acetylsalicylic Acid 80 mg","genericName":"Acetylsalicylic Acid 80 mg","slug":"acetylsalicylic-acid-80-mg","indication":"Other","status":"marketed"},{"name":"Anti-TNF suspended perioperatively","genericName":"Anti-TNF suspended perioperatively","slug":"anti-tnf-suspended-perioperatively","indication":"Other","status":"marketed"},{"name":"Anti-TNFα continued perioperatively","genericName":"Anti-TNFα continued perioperatively","slug":"anti-tnf-continued-perioperatively","indication":"Other","status":"marketed"},{"name":"PrEP using Truvada","genericName":"PrEP using Truvada","slug":"prep-using-truvada","indication":"Other","status":"marketed"},{"name":"Vitamin D chewable tablet supplementation","genericName":"Vitamin D chewable tablet supplementation","slug":"vitamin-d-chewable-tablet-supplementation","indication":"Vitamin D deficiency prevention and treatment","status":"marketed"},{"name":"Vitamin D pill supplementation","genericName":"Vitamin D pill supplementation","slug":"vitamin-d-pill-supplementation","indication":"Vitamin D deficiency prevention and treatment","status":"marketed"},{"name":"pr Sandoz Tamsulosin","genericName":"pr Sandoz Tamsulosin","slug":"pr-sandoz-tamsulosin","indication":"Benign prostatic hyperplasia (BPH) symptoms","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Bifilact®","genericName":"Bifilact®","slug":"bifilact","indication":"Restoration of normal intestinal microbiota in dysbiosis","status":"phase_3"},{"name":"Monthly antibiotic","genericName":"Monthly antibiotic","slug":"monthly-antibiotic","indication":"Bacterial infections requiring extended-duration therapy","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Brand-name latanoprost","genericName":"Brand-name latanoprost","slug":"brand-name-latanoprost","indication":"Open-angle glaucoma","status":"marketed"},{"name":"Generic latanoprost","genericName":"Generic latanoprost","slug":"generic-latanoprost","indication":"Open-angle glaucoma","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Enzalutamide capsule","genericName":"Enzalutamide capsule","slug":"enzalutamide-capsule","indication":"Metastatic castration-resistant prostate cancer","status":"phase_3"}]}],"pipeline":[{"name":"4CMenb","genericName":"4CMenb","slug":"4cmenb","phase":"marketed","mechanism":"4CMenb is a meningococcal serogroup B conjugate vaccine that stimulates immune responses against Neisseria meningitidis serogroup B.","indications":["Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B"],"catalyst":""},{"name":"SASS","genericName":"SASS","slug":"sass","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Acetylsalicylic Acid 80 mg","genericName":"Acetylsalicylic Acid 80 mg","slug":"acetylsalicylic-acid-80-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Anti-TNF suspended perioperatively","genericName":"Anti-TNF suspended perioperatively","slug":"anti-tnf-suspended-perioperatively","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Anti-TNFα continued perioperatively","genericName":"Anti-TNFα continued perioperatively","slug":"anti-tnf-continued-perioperatively","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bifilact®","genericName":"Bifilact®","slug":"bifilact","phase":"phase_3","mechanism":"Bifilact is a probiotic therapeutic that restores beneficial bacterial flora to treat or prevent gastrointestinal and related disorders.","indications":["Restoration of normal intestinal microbiota in dysbiosis","Gastrointestinal disorders associated with bacterial imbalance"],"catalyst":""},{"name":"Brand-name latanoprost","genericName":"Brand-name latanoprost","slug":"brand-name-latanoprost","phase":"marketed","mechanism":"Latanoprost is a prostaglandin F analog that binds to the prostaglandin F (FP) receptor to increase uveoscleral outflow of aqueous humor, thereby lowering intraocular pressure.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"Enzalutamide capsule","genericName":"Enzalutamide capsule","slug":"enzalutamide-capsule","phase":"phase_3","mechanism":"Enzalutamide is an androgen receptor inhibitor that blocks the binding and nuclear translocation of androgens, preventing androgen-driven gene transcription in prostate cancer cells.","indications":["Metastatic castration-resistant prostate cancer","Non-metastatic castration-resistant prostate cancer","Metastatic hormone-sensitive prostate cancer"],"catalyst":""},{"name":"Generic latanoprost","genericName":"Generic latanoprost","slug":"generic-latanoprost","phase":"marketed","mechanism":"Latanoprost is a prostaglandin F analog that binds to prostaglandin F receptors in the eye to increase uveoscleral outflow of aqueous humor, thereby lowering intraocular pressure.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"Monthly antibiotic","genericName":"Monthly antibiotic","slug":"monthly-antibiotic","phase":"marketed","mechanism":"A monthly antibiotic that provides extended-duration antimicrobial coverage through sustained-release formulation or long-acting delivery.","indications":["Bacterial infections requiring extended-duration therapy"],"catalyst":""},{"name":"PrEP using Truvada","genericName":"PrEP using Truvada","slug":"prep-using-truvada","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Vitamin D chewable tablet supplementation","genericName":"Vitamin D chewable tablet supplementation","slug":"vitamin-d-chewable-tablet-supplementation","phase":"marketed","mechanism":"Vitamin D supplementation provides cholecalciferol (vitamin D3) to maintain adequate serum vitamin D levels, supporting calcium absorption and bone health.","indications":["Vitamin D deficiency prevention and treatment","Support for bone health and calcium absorption"],"catalyst":""},{"name":"Vitamin D pill supplementation","genericName":"Vitamin D pill supplementation","slug":"vitamin-d-pill-supplementation","phase":"marketed","mechanism":"Vitamin D supplementation increases circulating 25-hydroxyvitamin D levels to support calcium homeostasis, bone health, and immune function.","indications":["Vitamin D deficiency prevention and treatment","Osteoporosis and bone health support","Calcium absorption enhancement"],"catalyst":""},{"name":"pr Sandoz Tamsulosin","genericName":"pr Sandoz Tamsulosin","slug":"pr-sandoz-tamsulosin","phase":"phase_3","mechanism":"Tamsulosin is an alpha-1 adrenergic receptor antagonist that relaxes smooth muscles in the prostate and bladder neck, improving urine flow.","indications":["Benign prostatic hyperplasia (BPH) symptoms","Lower urinary tract symptoms (LUTS)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxOalRzeVZRV0xIcjdlVE1pTm9FREE1emFmTXJPcDAyOVN2WU9XR2J2TEM3VHE5STEyOXVqa0haSy1ZMHM3T1BERnRuLXI0VEpNRTdkZ3ZTZm94S1ladDltS3pIaGxDbTlESkZnckJwbUd4REVjTWRyZ3dDRko5X0MzekIyY2ttdlZOZ0t6cEc1VnV0b3ZnOFBvd3MtODhPTElkVGV5N2FaV0JRT1o0eVJtMjFKWW9oM29zVkZMc004VmxuVENIbC1SV2w0aG5IRUgtZ1NpMXA5eTFQNmZVVVNGMkhLOVZkeHJ2X1F4X2FBRUhjTWNK?oc=5","date":"2025-12-03","type":"deal","source":"Newswire Canada","summary":"KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUÉBEC-UNIVERSITÉ LAVAL FOR THE DEPLOYMENT OF MEDHERIZE - Newswire Canada","headline":"KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUÉBEC-UNIVERSITÉ LAVAL FOR THE DEPLOYMENT OF MEDHERIZE","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-19","type":"regulatory","source":"Newswire Canada","summary":"Hyundai Hope on Wheels donates $250,000 to the Charles-Bruneau Foundation to support the art therapy program at the CHU de Québec-Université Laval Charles-Bruneau paediatric hematology oncology unit -","headline":"Hyundai Hope on Wheels donates $250,000 to the Charles-Bruneau Foundation to support the art therapy program at the CHU ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9XY2JLOEl4SVUwX1hibXNFQ0NpN3FhMEZzMzJwQU5HR2RrRjlMS1N3NDhHT0syWDFUcndyclhMVmpOQkZybV91c0J6OXYwZ1RfNGdQQTRmb2YtRzlzRFhz?oc=5","date":"2025-04-27","type":"pipeline","source":"Nature","summary":"Trends in medication use during the COVID-19 pandemic in Quebec, Canada - Nature","headline":"Trends in medication use during the COVID-19 pandemic in Quebec, Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNGR1VEU3M0lzYVNGOXFBUkd2VVRpWHRORG9yTjhJYXBtMkctM2JpNUU0bXBpR1N2VlZsd3JmRFhOdGx3X1JOZmRGdlRoY0FLRi00TG5sWFN2TE1vSVlVbEFoYW8ySmhibFoxUkY3MjBRZHBmTEpCcExuMDBEMUd5T2FJaVQtMmhRaUhOSHVteG9nRjVEdU9WekFtd3J4RV9aYk5HZjdaMXlMQ1B6aVFrYW5COE1Sdy1meE93?oc=5","date":"2024-11-13","type":"pipeline","source":"Innovation News Network","summary":"Defence Therapeutics welcomes Dr Svetlana Selivanova to board of directors - Innovation News Network","headline":"Defence Therapeutics welcomes Dr Svetlana Selivanova to board of directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE8xUlFEdFFOeTFVQ3VOSWQzQW1wczlBNmw0aVlxVGpIaGFVMEg3clB2TWxZcTNBeTFhRUx2cjVlSE1qaGlSYTRPeTRkWEpENzZPWThmOU9sWDAzSmFYODZrXzE5czExWm5fU01kWWZuVHY?oc=5","date":"2024-10-13","type":"pipeline","source":"Wiley Online Library","summary":"Ruminant Trans Fatty Acid Intake Modulates Inflammation Pathways in the Adipose Tissue Transcriptome of C57BL/6 Mice - Mohammadi - 2024 - Molecular Nutrition & Food Research - Wiley Online Library","headline":"Ruminant Trans Fatty Acid Intake Modulates Inflammation Pathways in the Adipose Tissue Transcriptome of C57BL/6 Mice - M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFBlOGp3dnN5Y0U1RDdkZ1VJMkowTkZkQVBEbFNCRVJxQzNkNzhBczFXQUtEUjNSMTJZQ0N5Ulp5X0VOOXJ3SHpUSkJVNFFreC1pLUlOaE80c1I?oc=5","date":"2024-06-21","type":"pipeline","source":"Journal of Nuclear Medicine","summary":"Nuclear Pharmacy Training in the Era of Theranostics: Toward Meeting the Needs of Nuclear Medicine Patients for Comprehensive Pharmaceutical Care - Journal of Nuclear Medicine","headline":"Nuclear Pharmacy Training in the Era of Theranostics: Toward Meeting the Needs of Nuclear Medicine Patients for Comprehe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9KM1B5Zm94NVdBVEJtNUlPMGNRY2JHLWVsUmJ6U0xuUW1WYWhxNy1nUHBnWUk2eWlCRk9ERVphc2dmYjhoZ1F6QXlwdmNPYjZPOVJPOElnU3BxczA0WUZV?oc=5","date":"2024-03-22","type":"trial","source":"Nature","summary":"A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation | Communications Medicine - Nature","headline":"A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supp","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSFpVdVlQRzkyS3d3YnJrejhYdWxDdmxTR0NLUTFuQWFxZ2dCYkR4QUh3TzJURkxjd09MOF9CdFVpM1hFazZIZHJnSHdIbVI2M3MyaS1FTjB5ZDUtZkxUaHRNNExPMnFwb1ZKWnAtLVFOUldsaXBUanR1Wi1oVG4zQkxHWE9hYTNX?oc=5","date":"2024-02-27","type":"pipeline","source":"Medical Xpress","summary":"Skin aging: A synergy between cigarette smoke and sunlight - Medical Xpress","headline":"Skin aging: A synergy between cigarette smoke and sunlight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPOGtUZ0NhR3gyaG13MFZibUY4QmxFdWJRRnd4Sm5LUWczb0s4ZzhQdm9pVzZRQTl4UzV3dXVhMXp2M3FlUTRZTlJmVERpQy16dFlLZW04VEVla1Y4bFFiLTRaYVBLV1J0QlVqSFJ6dFJIekZBNW40d3lVOWhuS3hVMURUQUhYUExONXhXWDMxaXNsUQ?oc=5","date":"2024-01-23","type":"trial","source":"Medical Xpress","summary":"Study finds 79% of Canadians support the therapeutic use of psilocybin for people at the end of life - Medical Xpress","headline":"Study finds 79% of Canadians support the therapeutic use of psilocybin for people at the end of life","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE05UFBhQ0EyTEg4d05vNTVNWmgyR2VfT1BUYWR0WUxVT0dNelhoZzR2VWJhdjNUOTdsdXI2UkowTUFMVEpzNXN3SDBzbjBrYVVxQkhFU0EwWjlYZ0R6RzY3UmZuYWJndw?oc=5","date":"2023-01-05","type":"pipeline","source":"Oxford Academic","summary":"Cerebrovascular insulin receptors are defective in Alzheimer’s disease - Oxford Academic","headline":"Cerebrovascular insulin receptors are defective in Alzheimer’s disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOMENJdllMODBLejMxQ1dNNnd3ODlYcWtqQlVJSkFzS0ZrSWVyeTZ6d1d5U2JzRG1MNHBENzVZUExBcHNzQjRKSlQtdl9DbjFuZWRYVW5NZDBWNHZpWGlYMzBpNkczcnM4d1RKWThiTXg4M3NRSW5aTU1LZ3Bia1Raei1VWU5lX3RLckNoT2xDQ0JSdHpnbUtpdFprZmlpdw?oc=5","date":"2022-10-26","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Alzheimer’s Disease Linked Brain Insulin Resistance Clarified - Genetic Engineering and Biotechnology News","headline":"Alzheimer’s Disease Linked Brain Insulin Resistance Clarified","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQbnNFMTV1ejBFcFdvQ1VHT2k3eWJjQUI0LWNxVTdiQXRPb0JRTWRQMmNkUVVCblBlVjlVSzhLNDJlM3doOEg3N3ZjZWhxSEdORnlsX2FSSldzVE9XRUtxOVM4dm9pWUxoa1VQVXR3Nm0tSy1QMllGeFotZy02WFVHNzRDelg0Q0FPUElKOG44Ymk4QQ?oc=5","date":"2022-10-25","type":"pipeline","source":"Open Access Government","summary":"The expansion of potential Alzheimer’s drugs - Open Access Government","headline":"The expansion of potential Alzheimer’s drugs","sentiment":"neutral"}],"patents":[],"drugCount":14,"phaseCounts":{"marketed":11,"phase_3":3},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}